Status:
COMPLETED
The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy
Lead Sponsor:
Aysen Orman
Conditions:
Epilepsies
White Matter Alterations
Eligibility:
All Genders
5-16 years
Brief Summary
Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter ...
Detailed Description
Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter ...
Eligibility Criteria
Inclusion
- Cranial MRI during the same period due to indications other than epilepsy;
- headache
- syncope and
- vertigo
Exclusion
- Patients with neuropsychiatric disorders;
- depression,
- psychotic disorders,
- autism spectrum disorder History of medication use for any chronic disease other than seizure medication, History of vascular disease ;
- Collagen tissue diseases;
- lupus,
- juvenile rheumatoid arthritis,
- polyarteritis nodosa,
- Kawasaki disease Demyelinating disease
- acute demyelinating disease (ADEM),
- Multiple sclerosis Acute symptomatic seizure or a single unprovoked seizure, İncomplete file data, or MRI performed at a location other than our hospital
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT06887504
Start Date
August 1 2019
End Date
April 1 2024
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mersin University
Mersin, Turkey, Turkey (Türkiye), 33343